Top compounds associated with response to BCL2L1


Feature Type Standardized
Nominal ANOVA
mRNA parbendazole CTRPv2 pan-cancer AAC -0.28 9e-18
mRNA KX2-391 CTRPv2 pan-cancer AAC -0.28 2e-16
mRNA vincristine CTRPv2 pan-cancer AAC -0.25 1e-14
mRNA rigosertib CTRPv2 pan-cancer AAC -0.26 3e-14
mRNA SB-743921 CTRPv2 pan-cancer AAC -0.26 3e-14
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.24 4e-14
mRNA nakiterpiosin CTRPv2 pan-cancer AAC -0.26 8e-14
mRNA CHM-1 CTRPv2 pan-cancer AAC -0.25 5e-13
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.24 2e-12
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.24 7e-12
Download CSV